Online citations, reference lists, and bibliographies.
← Back to Search

Copoly(styrene-maleic Acid)-pirarubicin Micelles: High Tumor-targeting Efficiency With Little Toxicity.

K. Greish, A. Nagamitsu, J. Fang, H. Maeda
Published 2005 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The copolymer of styrene-maleic acid (SMA) was used to construct micelles containing pirarubicin (4'-O-tetrahydropyranyladriamycin, or THP) as a new anticancer drug formulation. The procedure for the preparation of the micelles was simple, the component consisting of only SMA and pirarubicin in a noncovalent association, possibly by hydrophobic interaction between the styrene portion of SMA and pirarubicin chromophore. This method ensures more than 80% recovery of pirarubicin by weight, and 60% of drug loading (by weight) was achieved. The micelles obtained (SMA-THP) showed high solubility in water and a constant pirarubicin release rate of about 3-4%/day in vitro. SMA-THP micelles had an average molecular size of about 34 kDa according to gel chromatography; this size is a marked increase from the 627.6 Da of free THP, which suggests the formation of a micellar structure. When albumin was added, the molecular size of the micelles increased to about 94 kDa, which indicates binding to albumin, a unique characteristic of SMA. SMA-THP micelle preparation had a cytotoxic effect (93-101%) on MCF-7 breast cancer cells and SW480 human colon cancer cells in vitro that was comparable to that of free THP. An in vivo assay of SMA-THP at doses of 20 mg/kg in ddY mice bearing S-180 tumor revealed complete tumor eradication in 100% of tested animals. Mice survived for more than 1 year after treatment with micellar drug doses as high as 100 mg/kg pirarubicin equivalent. This marked antitumor activity can be attributed to the enhanced permeability and retention (EPR) effect of macromolecular drugs seen in solid tumors, which enables selective delivery of drugs to tumor and thus much fewer side effects. Complete blood counts, liver function test, and cardiac histology showed no sign of adverse effects for intravenous doses of the micellar preparation. These data thus suggest that intravenous administration of the SMA-THP micellar formulation can enhance the therapeutic effect of pirarubicin more than 50-fold.



This paper is referenced by
10.1080/1061186X.2019.1566341
Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor
K. Greish (2019)
10.1021/bc800449s
Ring-opening metathesis polymerization-based synthesis of ICG-containing amphiphilic triblock copolymers for in vivo tumor imaging.
K. Miki (2009)
10.1021/mp400687w
Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer.
H. Wang (2014)
Stealth poly(lactic-co-glycolic acid) - diiodinated boron dipyrromethene nanoparticles to improve tumour selectivity in photodynamic cancer therapy /Voon Siew Hui
Siew Hui Voon (2016)
10.1021/ACS.MOLPHARMACEUT.6B00697
Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
H. Nakamura (2016)
10.1016/j.ejpb.2012.04.016
HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: In vitro and in vivo anticancer effect.
J. Fang (2012)
10.1016/j.ijpharm.2008.08.011
Antitumor activity of adriamycin-incorporated polymeric micelles of poly(gamma-benzyl L-glutamate)/poly(ethylene oxide).
Young-Il Jeong (2009)
10.1016/j.colsurfb.2015.11.032
pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
Atsuyuki Saisyo (2016)
10.1201/B13159-5
Pegylated Zinc Protoporphyrin: A Micelle-Forming Polymeric Drug for Cancer Therapy
Jun Fang (2012)
10.1080/10611860701539584
Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines
K. Greish (2007)
10.1016/j.colsurfb.2013.02.002
Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: preparation and in vitro evaluation in human lung adenocarcinoma cells.
G. Yordanov (2013)
10.1016/J.BIOMATERIALS.2006.11.051
High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor.
A. Iyer (2007)
10.1016/j.bpc.2016.04.002
Synthesis and characterization of a pH responsive folic acid functionalized polymeric drug delivery system.
Xia Li (2016)
10.1016/J.COLSURFA.2015.10.009
Albumin-stabilized epirubicin nanocarriers of core–shell type based on poly(butyl cyanoacrylate) and poly(styrene-co-maleic acid)
Nadezhda Angelova (2015)
10.1016/j.ijpharm.2012.04.048
Paclitaxel-incorporated nanoparticles of hydrophobized polysaccharide and their antitumor activity.
S. Lee (2012)
10.1002/jbm.a.34850
Multifunctional nanomicellar systems for delivering anticancer drugs.
Y. Chen (2014)
and therapeutic target in neoplastic mast cells Identification of heat shock protein 32 (Hsp32) as a novel survival factor
Harald Esterbauer (2013)
10.1021/bm100561v
Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery.
F. Li (2010)
10.1016/j.ejps.2012.02.013
Influence of coupling bonds on the anti-tumor activity of polymer-pirarubicin conjugates.
G. Mo (2012)
10.18632/oncotarget.20650
A CARP-1 functional mimetic loaded vitamin E-TPGS micellar nano-formulation for inhibition of renal cell carcinoma
V. Cheriyan (2017)
10.1007/s13346-011-0042-2
Paclitaxel- and lapatinib-loaded lipopolymer micelles overcome multidrug resistance in prostate cancer
Feng Li (2011)
10.2147/IJN.S32069
Amphiphilic graft copolymer based on poly(styrene-co-maleic anhydride) with low molecular weight polyethylenimine for efficient gene delivery
X. Duan (2012)
10.1016/J.COLSURFA.2014.03.106
Nanoparticles of poly(styrene-co-maleic acid) as colloidal carriers for the anticancer drug epirubicin
Nadezhda Angelova (2014)
10.1186/s40169-018-0185-6
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
H. Maeda (2018)
10.1111/j.1349-7006.2010.01619.x
In vitro and in vivo evaluation of tumor targeting styrene‐maleic acid copolymer‐pirarubicin micelles: Survival improvement and inhibition of liver metastases
J. Daruwalla (2010)
10.1258/ebm.2009.009304
Tissue protective effect of xanthine oxidase inhibitor, polymer conjugate of (styrene–maleic acid copolymer) and (4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine), on hepatic ischemia–reperfusion injury
J. Fang (2010)
10.1016/j.ejpb.2008.11.010
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
H. Maeda (2009)
10.1002/DDR.20069
Targeted nanoparticles for detecting and treating cancer
C. J. Sunderland (2006)
10.1517/13543776.17.7.819
Polymeric micelles as nanocarriers for drug delivery
Liyan Qiu (2007)
10.1007/978-1-4419-0131-6_3
Tumor-Targeted Macromolecular Drug Delivery Based on the Enhanced Permeability and Retention Effect in Solid Tumor
T. Seki (2009)
10.1021/nl300630c
Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution.
Daniel J. Callahan (2012)
10.1142/9781860949074_0005
Polymer micelles as drug carriers
E. Batrakova (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar